16:09 EDT Glaukos (GKOS) sees FY25 revenue $490M-$495M, consensus $484.6M
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GKOS:
- Glaukos Corp. Advances NEXAGON® Study for Eye Condition Treatment
- Glaukos Corp. Advances in Glaucoma Treatment with New Clinical Trial
- Glaukos Corp.’s iDose TR Study: A Potential Game-Changer in Ophthalmic Treatment
- Microsoft upgraded, Harley-Davidson downgraded: Wall Street’s top analyst calls
- Wells Fargo upgrades Glaukos on ‘underappreciated’ growth opportunity